# Medley Pharmaceuticals Limited – FDA Inspection, May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/medley-pharmaceuticals-limited/38f497cb-2f3a-4131-b18a-d03dc1d9c5f0
Source feed: FDA_Inspections

> FDA inspection 1205651 of Medley Pharmaceuticals Limited, May 19, 2023. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205651
- Company Name: Medley Pharmaceuticals Limited
- Inspection Date: 2023-05-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1098331 - 2019-07-31](https://www.keypedia.com/records/fda_inspections/medley-pharmaceuticals-limited/0fb9d332-e223-48e4-b0fa-211413e829b2)
- [FDA Inspection 1154972 - 2018-12-14](https://www.keypedia.com/records/fda_inspections/medley-pharmaceuticals-limited/4603a164-174b-4a55-ba3e-3ca32c2768bf)
- FDA Inspection 973541 - 2016-02-19

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)

Company: https://www.keypedia.com/companies/medley-pharmaceuticals-limited/e3271248-7900-4155-a7db-66f64fa0936b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c